Leveraging Computational Analysis & AI/ML to Accelerate Oligonucleotide Drug Discovery and Development
26 Jun 2025
Oligonucleotide Discovery
- Utilizing machine learning algorithms to predict stability, target affinity, and off-target effects for enhanced therapeutic development
- Applying in silico simulations to improve sequence selection, impurity profiling, and manufacturability
- Overcoming data integration challenges to ensure computationally designed oligonucleotides translate effectively into preclinical and clinical success
Industry Expert
